Advertisement
Screener

Rocket One Inc. (RKTO) Deferred Tax Assets, Valuation Allowance

1.0 / 5 stars · 9/43 Roast Me

Rocket One Inc. Deferred Tax Assets, Valuation Allowance

Rocket One Inc. (RKTO) had Deferred Tax Assets, Valuation Allowance of $21.26 million as of 2025-12-31, per its 10-K filed 2026-03-27.

Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-03-27

  • 2025-12-31: Deferred Tax Assets, Valuation Allowance $21.26M.
  • 2024-12-31: Deferred Tax Assets, Valuation Allowance $17.67M.
  • 2023-12-31: Deferred Tax Assets, Valuation Allowance $15.19M; Deferred Tax Assets, Valuation Allowance as first filed $15.31M.
  • 2022-12-31: Deferred Tax Assets, Valuation Allowance $12.81M.
Period endDeferred Tax Assets, Valuation AllowanceDeferred Tax Assets, Valuation Allowance as first filed
2025-12-31$21.26M
10-K · filed 2026-03-27
2024-12-31$17.67M
10-K · filed 2026-03-27
2023-12-31$15.19M
10-K · filed 2025-03-28
$15.31M
10-K · filed 2024-03-28
2022-12-31$12.81M
10-K · filed 2024-03-28
2021-12-31$8.28M
10-K · filed 2023-03-31
2020-12-31$4.03M
10-K · filed 2022-03-30
2019-12-31$2.54M
10-K · filed 2021-03-16
2018-12-31$843.17K
10-K · filed 2020-03-02
2017-12-31$425.39K
10-K · filed 2019-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Lipocine Inc. (LPCN)United States$0.017B-1.79
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52